HQY has been the topic of several other research reports. Citigroup reissued a buy rating on shares of Healthequity in a research note on Friday, June 28th. Zacks Investment Research raised Healthequity from a strong sell rating to a hold rating in a research note on Tuesday, May 21st. JPMorgan Chase & Co. set a $80.00 target price on Healthequity and gave the company an overweight rating in a research note on Wednesday, June 5th. Raymond James lifted their target price on Healthequity from $85.00 to $90.00 and gave the company an outperform rating in a research note on Friday, July 19th. Finally, BidaskClub raised Healthequity from a hold rating to a buy rating in a research note on Friday, July 19th. Two analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Healthequity currently has an average rating of Buy and a consensus price target of $87.92.
Shares of HQY opened at $72.72 on Tuesday. The company’s 50 day simple moving average is $72.47. The company has a market cap of $4.56 billion, a P/E ratio of 76.55, a PEG ratio of 3.83 and a beta of 1.47. Healthequity has a 12-month low of $50.29 and a 12-month high of $101.58. The company has a debt-to-equity ratio of 0.07, a current ratio of 15.60 and a quick ratio of 15.59.
In other news, CEO Jon Kessler acquired 10,000 shares of Healthequity stock in a transaction on Friday, July 12th. The shares were acquired at an average price of $61.00 per share, with a total value of $610,000.00. Following the purchase, the chief executive officer now directly owns 442,410 shares in the company, valued at approximately $26,987,010. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Delano Ladd sold 6,875 shares of Healthequity stock in a transaction that occurred on Monday, July 22nd. The stock was sold at an average price of $80.00, for a total value of $550,000.00. Following the completion of the sale, the executive vice president now directly owns 17,833 shares in the company, valued at approximately $1,426,640. The disclosure for this sale can be found here. In the last ninety days, insiders sold 37,899 shares of company stock worth $2,780,851. Corporate insiders own 3.70% of the company’s stock.
A number of large investors have recently added to or reduced their stakes in HQY. Deutsche Bank AG increased its position in shares of Healthequity by 29.7% during the 4th quarter. Deutsche Bank AG now owns 383,388 shares of the company’s stock valued at $22,867,000 after purchasing an additional 87,736 shares during the last quarter. Neuburgh Advisers LLC increased its position in shares of Healthequity by 5.6% during the 1st quarter. Neuburgh Advisers LLC now owns 31,600 shares of the company’s stock valued at $2,338,000 after purchasing an additional 1,664 shares during the last quarter. Bfsg LLC bought a new position in shares of Healthequity during the 1st quarter valued at approximately $460,000. Sawtooth Solutions LLC bought a new position in shares of Healthequity during the 1st quarter valued at approximately $325,000. Finally, Keeler Thomas Management LLC increased its position in shares of Healthequity by 9.9% during the 1st quarter. Keeler Thomas Management LLC now owns 16,730 shares of the company’s stock valued at $1,237,000 after purchasing an additional 1,505 shares during the last quarter. 96.49% of the stock is currently owned by institutional investors and hedge funds.
Healthequity Company Profile
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Story: Key terms to understand channel trading
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.